Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]
Top Cited Papers
- 6 May 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 70 (19) , 1691-1698
- https://doi.org/10.1212/01.wnl.0000311391.00944.c4
Abstract
Objective: To perform an evidence-based review of the safety and efficacy of botulinum neurotoxin (BoNT) in the treatment of adult and childhood spasticity. Methods: A literature search was performed including MEDLINE and Current Contents for therapeutic articles relevant to BoNT and spasticity. Authors reviewed, abstracted, and classified articles based on American Academy of Neurology criteria (Class I–IV). Results: The highest quality literature available for the respective indications was as follows: adult spasticity (14 Class I studies); spastic equinus and adductor spasticity in pediatric cerebral palsy (six Class I studies). Recommendations: Botulinum neurotoxin should be offered as a treatment option for the treatment of spasticity in adults and children (Level A).Keywords
This publication has 0 references indexed in Scilit: